Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Livanios (Athens, Greece), E. Dimakakos (Athens, Greece), A. Charpidou (Athens, Greece), D. Vassos (Athens, Greece), P. Polydorou (Athens, Greece), D. Grapsa (Athens, Greece), E. Kainis (Athens, Greece), K. Syrigos (Athens, Greece). Venous thromboembolic disease in patients with small cell lung cancer: incidence and clinicopathological risk factors. 3455

Member's Comments

No comment yet.

Related content which might interest you: The incidence of serious venous thromboembolic events in 1157 lung cancer patients Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008 Evaluation of cancer-associated thrombosis risk in patients with lung adenocarcinoma using the COMPASS-CAT risk assessment model Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer Source: Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017 Year: 2018 Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Frequency of thromboembolic events in patients with lung cancer at the time of diagnosis and in the course of disease Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011 Cumulative incidence and associated risk factor of chronic pulmonary infection after lung resection surgery for lung cancer Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Interstital lung disease rates and risk factors in a UK lung cancer screening trial Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Preoperative biopsy risk for recurrence?: A retrospective study of risk factors for recurrence of stage 1A non-small cell lung cancer Source: International Congress 2017 – How to reach peripheral lesions: (radial EBUS, CLE, navigation, etc.) and treat airleaks Year: 2017 Risk factors for cardiac complications after lung cancer surgery Source: Eur Respir J 2004; 24: Suppl. 48, 172s Year: 2004 Comparison of risk prediction scores for venous thromboembolism in lung cancer patients: a retrospective cohort study Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Risk factors for vascular events during lung cancer chemotherapy Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Risk of venous thromboembolism in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Incidence and risk factors for structural lung disease following SARS-CoV-2 infection Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer? Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 Lung cancer and hemostasis – the impact of subclinical thrombotic manifestations upon the prognosis: a prospective hospital study Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006 The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Venous thromboembolic disease and bronchial cancer Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Chronic obstructive pulmonary disease is an independent risk factor for nonsmall cell lung cancer in smokers Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002 Characteristics, incidence, risk factors, and practical management of pneumonitis associated with anti-PD-1 immunotherapy in patients with non-small cell lung cancer Source: International Congress 2019 – Treatment of lung cancer Year: 2019